What is the epidemiology of hepatitis B?

In 2018, a total of 3,322 cases of acute hepatitis B were reported to CDC, for an overall incidence rate of 1.0 cases per 100,000 population. After adjusting for under-ascertainment and under-reporting, an estimated 21,600 acute hepatitis B cases occurred in 2018.

How big is the financial burden of hepatitis B to society a cost of illness study of hepatitis B infection in Singapore?

The estimated total annual cost of chronic HBV infection and its associated complications in Singapore was US$279 million (range US$34-941 million when allowing various assumptions as tested by the sensitivity analyses), with 58% or US$161 million attributable to direct cost.

What is the treatment success rate for hepatitis B?

For patients taking entecavir up to 5 years, 94% achieved undetectable HBV DNA and 80% had normal ALT levels. After 96 weeks of treatment, 31% had HBeAg seroconversion; 5.1% also had HBsAg seroconversion.

What is the treatment for hepatitis B carrier?

Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver.

Is hepatitis B curable or treatable?

Most adults with hepatitis B recover fully, even if their signs and symptoms are severe. Infants and children are more likely to develop a chronic (long-lasting) hepatitis B infection. A vaccine can prevent hepatitis B, but there’s no cure if you have the condition.

How many years can a hepatitis B patient live?

The estimated carrier life expectancy is 71.8 years, as compared to 76.2 years among noncarriers (Figure ​ 5). These results are consistent with other estimates, which indicate that 15% to 40% of HBV carriers die of liver complications.

https://www.youtube.com/watch?v=B2ZFVZVGxpE